Ni Fubiao, Tang Hengjie, Wang Cheng, Wang Zixiang, Yu Fangyi, Chen Bicheng, Sun Linxiao
Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, Zhejiang Provincial Top Key Discipline in Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
First College of Clinical Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Cancer Manag Res. 2019 Sep 13;11:8391-8405. doi: 10.2147/CMAR.S217375. eCollection 2019.
Current investigations suggest that the Base Excision Repair (BER) system may change DNA repair capacity and affect clinical gastric cancer progression such as overall survival. However, the prognostic value of BER system members in gastric cancer remains unclear.
We explored the prognostic correlation between 7 individual BER genes, including uracil-DNA glycosylase (UNG), Single-strand-selective monofunctional uracil-DNA glycosylase 1 (SMUG1), Methyl-CpG binding domain 4 (MBD4), thymine DNA glycosylase (TDG), 8-oxoguanine DNA glycosylase (OGG1), MutY DNA glycosylase (MUTYH) and Nei like DNA glycosylase 1 (NEIL1), expression and overall survival (OS) in different clinical data, such as Lauren classification, pathological stages, human epidermal growth factor receptor-2 (HER2) expression status, treatment strategy, gender and differentiation degree in gastric cancer patients, using Kaplan-Meier plotter (KM plotter) online database. Based on the bioinformatics analysis, we utilized Berzosertib (VE-822) to inhibit DNA damage repair in cancer cells compared to solvent control group via real-time cellular analysis (RTCA), flow cytometry, colony formation and migration assay. Finally, we utilized reverse transcription-polymerase chain reaction (RT-PCR) to confirm the expression of BER members between normal and two gastric cancer cells or solvent and VE-822 treated groups.
Our work revealed that high UNG mRNA expression was correlated with high overall survival probability; however, high SMUG1, MBD4, TDG, OGG1, MUTYH and NEIL1 mRNA expression showed relatively low overall survival probability in all GC patients. Additionally, UNG was associated with high overall survival probability in intestinal and diffuse types, but SMUG1 and NEIL1 showed opposite results. Further, VE-822 pharmacological experiment suggested that inhibition of DNA damage repair suppressed gastric cancer cells' proliferation and migration ability via inducing apoptosis. Further, real-time polymerase chain reaction results proposed the inhibition of gastric cancer cells by VE-822 may be through UNG, MUTYH and OGG-1 of BER system.
We comprehensively analyze the prognostic value of the BER system (UNG, SMUG1, MBD4, TDG, OGG1, MUTYH and NEIL1) based on bioinformatics analysis and experimental confirmation. BER members are associated with distinctive prognostic significance and maybe new valuable prognostic indicators in gastric cancer.
目前的研究表明,碱基切除修复(BER)系统可能会改变DNA修复能力,并影响临床胃癌进展,如总生存期。然而,BER系统成员在胃癌中的预后价值仍不清楚。
我们利用Kaplan-Meier plotter(KM plotter)在线数据库,探讨了7个个体BER基因,包括尿嘧啶-DNA糖基化酶(UNG)、单链选择性单功能尿嘧啶-DNA糖基化酶1(SMUG1)、甲基-CpG结合结构域4(MBD4)、胸腺嘧啶DNA糖基化酶(TDG)、8-氧代鸟嘌呤DNA糖基化酶(OGG1)、MutY DNA糖基化酶(MUTYH)和Nei样DNA糖基化酶1(NEIL1)的表达与不同临床数据(如劳伦分类、病理分期、人表皮生长因子受体-2(HER2)表达状态、治疗策略、性别和胃癌患者的分化程度)中总生存期(OS)的预后相关性。基于生物信息学分析,与溶剂对照组相比,我们通过实时细胞分析(RTCA)、流式细胞术、集落形成和迁移试验,利用Berzosertib(VE-822)抑制癌细胞中的DNA损伤修复。最后,我们利用逆转录-聚合酶链反应(RT-PCR)来确认正常细胞与两种胃癌细胞之间或溶剂组与VE-822处理组之间BER成员的表达。
我们的研究表明,UNG mRNA高表达与高总生存概率相关;然而,在所有胃癌患者中,SMUG1、MBD4、TDG、OGG1、MUTYH和NEIL1 mRNA高表达显示出相对较低的总生存概率。此外,UNG在肠型和弥漫型中与高总生存概率相关,但SMUG1和NEIL1显示出相反的结果。此外,VE-822药理实验表明,抑制DNA损伤修复通过诱导凋亡抑制胃癌细胞的增殖和迁移能力。此外,实时聚合酶链反应结果表明,VE-822对胃癌细胞的抑制作用可能是通过BER系统的UNG、MUTYH和OGG-1实现的。
我们基于生物信息学分析和实验证实,全面分析了BER系统(UNG、SMUG1、MBD4、TDG、OGG1、MUTYH和NEIL1)的预后价值。BER成员具有独特的预后意义,可能是胃癌中有价值的新预后指标。